Cortexyme, Inc is a biotechnology business based in the US. Cortexyme shares (CRTX) are listed on the NASDAQ and all prices are listed in US Dollars. Cortexyme employs 37 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Cortexyme
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cortexyme stock price (NASDAQ: CRTX)Use our graph to track the performance of CRTX stocks over time.
Cortexyme shares at a glance
|Latest market close||$41.37|
|52-week range||$26.66 - $65.70|
|50-day moving average||$53.21|
|200-day moving average||$40.75|
|Wall St. target price||$73.86|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.17|
Buy Cortexyme shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cortexyme stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cortexyme price performance over time
|1 week (2021-07-13)||N/A|
|1 month (2021-06-24)||-29.47%|
|3 months (2021-04-20)||N/A|
|6 months (2021-01-20)||N/A|
|1 year (2020-07-20)||N/A|
|2 years (2019-07-20)||N/A|
|3 years (2018-07-20)||N/A|
|5 years (2016-07-20)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-25.99%|
|Return on equity TTM||-44.19%|
|Market capitalisation||$1.9 billion|
TTM: trailing 12 months
Shorting Cortexyme shares
There are currently 3.0 million Cortexyme shares held short by investors – that's known as Cortexyme's "short interest". This figure is 14.2% down from 3.6 million last month.
There are a few different ways that this level of interest in shorting Cortexyme shares can be evaluated.
Cortexyme's "short interest ratio" (SIR)
Cortexyme's "short interest ratio" (SIR) is the quantity of Cortexyme shares currently shorted divided by the average quantity of Cortexyme shares traded daily (recently around 242816.57370518). Cortexyme's SIR currently stands at 12.55. In other words for every 100,000 Cortexyme shares traded daily on the market, roughly 12550 shares are currently held short.
However Cortexyme's short interest can also be evaluated against the total number of Cortexyme shares, or, against the total number of tradable Cortexyme shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cortexyme's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Cortexyme shares in existence, roughly 100 shares are currently held short) or 0.1708% of the tradable shares (for every 100,000 tradable Cortexyme shares, roughly 171 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Cortexyme.
Find out more about how you can short Cortexyme stock.
Cortexyme share dividends
We're not expecting Cortexyme to pay a dividend over the next 12 months.
Cortexyme share price volatility
Over the last 12 months, Cortexyme's shares have ranged in value from as little as $26.6612 up to $65.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cortexyme's is 0.7592. This would suggest that Cortexyme's shares are less volatile than average (for this exchange).
Cortexyme, Inc. , a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California. .
Stocks similar to Cortexyme
Cortexyme in the news
Cortexyme Announces Lead 3CLpro Inhibitor for the Treatment of Coronavirus Infection
Biotech Bonanza: Promising Second Half Outlook
Cortexyme Selects 3CLpro Inhibitor As COVID-19 Candidate
Frequently asked questionsWhat percentage of Cortexyme is owned by insiders or institutions?
Currently 33.195% of Cortexyme shares are held by insiders and 62.962% by institutions. How many people work for Cortexyme?
Latest data suggests 37 work at Cortexyme. When does the fiscal year end for Cortexyme?
Cortexyme's fiscal year ends in December. Where is Cortexyme based?
Cortexyme's address is: 269 East Grand Avenue, South San Francisco, CA, United States, 94080 What is Cortexyme's ISIN number?
Cortexyme's international securities identification number is: US22053A1079 What is Cortexyme's CUSIP number?
Cortexyme's Committee on Uniform Securities Identification Procedures number is: 22053A107
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert